Previous close | 26.01 |
Open | 26.11 |
Bid | 30.30 |
Ask | 30.90 |
Strike | 70.00 |
Expiry date | 2024-01-19 |
Day's range | 26.01 - 26.11 |
Contract range | N/A |
Volume | |
Open interest | N/A |
High-quality dividend stocks can be a great way to tilt the odds in your favor as an investor. The core reason is that top-shelf dividend stocks generally have a long-standing shareholder base due to the reliability of their payouts.
AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two of the world's biggest pharmaceutical companies, and the similarities don't end there. The case for AbbVie as a growth stock can't avoid two issues: the decline of Humira, and the stagnation of its oncology portfolio.
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.